Comparison of the Effect of Warfarin and Direct Oral Anticoagulants

NCT06269302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 346

Last updated 2024-02-21

No results posted yet for this study

Summary

In this study, it was aimed to compare the frequency of new oral anticoagulants and warfarin usage, and to reveal the rates of recurrent upper gastrointestinal bleeding among patients who applied to our hospital with upper gastrointestinal bleeding

Conditions

  • Anticoagulants and Bleeding Disorders
  • Gastrointestinal Hemorrhage

Sponsors & Collaborators

  • Samsun Education and Research Hospital

    lead OTHER

Principal Investigators

  • DÜRİYE SILA KARAGÖZ ÖZEN, MD · Samsun Education and Research Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06269302 on ClinicalTrials.gov